CorrespondenceNovel anoctamin-3 missense mutation responsible for early-onset myoclonic dystonia
Section snippets
Author's role
AD, PB and DG were involved in the care of the patient. JC, ND, CT and MA were involved in genetic analysis and interpretation. AD and PB wrote and reviewed the manuscript, JC, DG and MA reviewed the manuscript. All authors approved the final version of the manuscript.
Ethical statement
Informed consent was obtained from the patient for publication of his data and video, including online publication and dissemination.
Conflicts of interest
None of the authors has a conflict of interest in relation to the present article.
Acknowledgments and financial disclosures
MA declares honoraria and travel grants from Abbvie, Actelion Pharmaceuticals, UCB, Orkyn and Aguettant. AD declares a grant from Fondation pour la Recherche Médicale (FDM201806005951). JC, DG, PB, ND, CT have no financial disclosures to declare.
References (24)
- et al.
Mutations in ANO3 cause dominant craniocervical dystonia: ion channel implicated in pathogenesis
Am. J. Hum. Genet.
(2012) - et al.
A recurrent de-novo ANO3 mutation causes early-onset generalized dystonia
J. Neurol. Sci.
(2019) - et al.
Early-onset generalized dystonia starting in the lower extremities in a patient with a novel ANO3 variant
Park. Relat. Disord.
(2018) - et al.
A missense mutation in KCTD17 causes autosomal dominant myoclonus-dystonia
Am. J. Hum. Genet.
(2015) - et al.
Childhood onset progressive myoclonic dystonia due to a de novo KCTD17 splicing mutation
Park. Relat. Disord.
(2019) - et al.
A novel KCTD17 mutation is associated with childhood early-onset hyperkinetic movement disorder
Park. Relat. Disord.
(2019) Myoclonus-dystonia syndrome
Handb. Clin. Neurol.
(2011)- et al.
Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome
Nat. Genet.
(2001) - et al.
Myoclonus-dystonia: classification, phenomenology, pathogenesis, and treatment
Curr. Opin. Neurol.
(2018) - et al.
Assessment of a targeted gene panel for identification of genes associated with movement disorders
JAMA Neurology
(2018)
Development and validation of a rapid PCR method for the PowerPlex(R) 16 HS system for forensic DNA identification
Int. J. Leg. Med.
(2015)
CADD: predicting the deleteriousness of variants throughout the human genome
Nucleic Acids Res.
(2019)
Cited by (0)
© 2019 Elsevier Ltd. All rights reserved.